Sijin Guo

Sijin Guo

Auto-generated profile, based on publicly available information

Sijin Guo

Center for RNA Nanobiotechnology and Nanomedicine, The Ohio State University, Columbus, OH, 43210, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSijin Guo
Sijin Guo
MVMario Vieweger
Mario Vieweger
KZKaiming Zhang
Kaiming Zhang
HYHongran Yin
Hongran Yin
HWHongzhi Wang
Hongzhi Wang
Peixuan GuoPeixuan Guo
Peixuan Guo
Paclitaxel is widely used in cancer treatments, but poor water-solubility and toxicity raise serious concerns. Here we report an RNA four-way junction nanoparticle with ultra-thermodynamic stability to solubilize and load paclitaxel for targeted cancer therapy. Each RNA nanoparticle covalently loads twenty-four paclitaxel molecules as a prodrug. The RNA-paclitaxel complex is structurally rigid and stable, demonstrated by the sub-nanometer resolution imaging of cryo-EM. Using RNA nanoparticles as carriers increases the water-solubility of paclitaxel by 32,000-fold. Intravenous injections of RNA-paclitaxel nanoparticles with specific cancer-targeting ligand dramatically inhibit breast cancer growth, with nearly undetectable toxicity and immune responses in mice. No fatalities are observed at a paclitaxel dose equal to the reported LD 50 . The use of ultra-thermostable RNA nanoparticles to deliver chemical prodrugs addresses issues with RNA unfolding and nanoparticle dissociation after high-density drug loading. This finding provides a stable nano-platform for chemo-drug delivery as well as an efficient method to solubilize hydrophobic drugs.